07:00 , Mar 26, 2012 |  BC Week In Review  |  Company News

Arctic Partners, Opko deal

Opko exercised its first right of refusal under a January deal for additional information, patents, know-how, property and technology associated with time-resolved fluorescence detection technology. Opko said the technology can be used to assess the...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

Arctic Partners, Opko deal

Opko acquired exclusive rights to two kallikrein family biomarkers from Arctic Partners. Opko said it will develop a prostate cancer screening test using the biomarkers and prostate specific antigen (PSA) to predict initial biopsy results...